Impacts of cytosolic phospholipase A2, 15-prostaglandin dehydrogenase, and cyclooxygenase-2 expressions on tumor progression in colorectal cancer.
about
Group IVA Cytosolic Phospholipase A2 Regulates the G2-to-M Transition by Modulating the Activity of Tumor Suppressor SIRT2.Identification of a novel class of anti-inflammatory compounds with anti-tumor activity in colorectal and lung cancers.Identification and development of mPGES-1 inhibitors: where we are at?Expression of 15-hydroxyprostaglandin dehydrogenase and cyclooxygenase-2 in non-small cell lung cancer: Correlations with angiogenesis and prognosisDelineating metabolic signatures of head and neck squamous cell carcinoma: phospholipase A2, a potential therapeutic target.Targeting cytosolic phospholipase A2 α in colorectal cancer cells inhibits constitutively activated protein kinase B (AKT) and cell proliferation.Phase II study of the effects of ginger root extract on eicosanoids in colon mucosa in people at normal risk for colorectal cancer.Cyclooxygenase-2 expression as a predictor of outcome in colorectal carcinoma.Gender-specific genomic profiling in metastatic colorectal cancer patients treated with 5-fluorouracil and oxaliplatin.Inhibitors of microsomal prostaglandin E2 synthase-1 enzyme as emerging anti-inflammatory candidates.Prognostic implication of 15-hydroxyprostaglandin dehydrogenase down-regulation in patients with colorectal cancer.Prognostic significance of cytosolic phospholipase A2 expression in patients with colorectal cancerNanoliposomal delivery of cytosolic phospholipase A2 inhibitor arachidonyl trimethyl ketone for melanoma treatment.CD147 and Cyclooxygenase Expression in Feline Oral Squamous Cell Carcinoma
P2860
Q27320850-7AAC5B0B-928D-43EA-8607-F1CF4E9A8E7CQ34024178-3CAFC357-5D54-481C-9CBB-C54C6DC15C38Q34056458-E8397159-2ACD-40AF-8C3D-71428DA0D89EQ34141517-66763768-F50E-4A45-B885-A697F483AB22Q34320362-3864CE86-18F4-4F89-B264-93732D908394Q35067937-D2615C0E-D4E3-4B7A-AD92-F9682FF073CCQ35529214-C691F400-0F6D-432A-BF92-85934CDBED65Q35904309-B2E6C3BB-9914-4AC6-ACB6-54D71C4F448BQ37332789-1F0D1B9F-7D77-42C7-A8E6-D95F0E2A6491Q38229056-8FC42D0C-6EBD-454F-980D-831F91858E89Q38456118-8C0FD032-E8E1-4BE0-8772-B490AE241946Q38876499-BC86B4CD-6E05-41E4-86A9-162914D04D12Q50113740-A28FBB1C-9324-472F-9D3D-A9E60539A962Q58783982-647A05F0-517A-4D81-8F61-1EC6D3A93B11
P2860
Impacts of cytosolic phospholipase A2, 15-prostaglandin dehydrogenase, and cyclooxygenase-2 expressions on tumor progression in colorectal cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Impacts of cytosolic phospholi ...... gression in colorectal cancer.
@ast
Impacts of cytosolic phospholi ...... gression in colorectal cancer.
@en
Impacts of cytosolic phospholi ...... gression in colorectal cancer.
@nl
type
label
Impacts of cytosolic phospholi ...... gression in colorectal cancer.
@ast
Impacts of cytosolic phospholi ...... gression in colorectal cancer.
@en
Impacts of cytosolic phospholi ...... gression in colorectal cancer.
@nl
prefLabel
Impacts of cytosolic phospholi ...... gression in colorectal cancer.
@ast
Impacts of cytosolic phospholi ...... gression in colorectal cancer.
@en
Impacts of cytosolic phospholi ...... gression in colorectal cancer.
@nl
P2093
P2860
P1476
Impacts of cytosolic phospholi ...... gression in colorectal cancer.
@en
P2093
Cheol Hee Choi
Kyung Jong Kim
Sung Chul Lim
Sung Soo Kim
Tae Bum Lee
Young Don Min
P2860
P304
P356
10.3349/YMJ.2010.51.5.692
P577
2010-09-01T00:00:00Z